Showing results (1071-1080 of 1,086) with videos related to

Sort By:
Pageof 109
American Heart Journal|February 23, 2025
Effects of carvedilol on the prevention of cardiotoxicity induced by anthracyclines: Design and rationale of the CARDIOTOX trialIsabela Bispo Santos da Silva Costa, Remo H M Furtado, Luciano F Drager, et al.
Blood|May 19, 2021
Core-binding factor leukemia hijacks the T-cell-prone PU.1 antisense promoterE van der Kouwe, G Heller, A Czibere, et al.
Blood|January 20, 2026
Plasmin modulates neutrophilic inflammation and alveolar macrophage function, protecting mice from pneumococcal pneumoniaCamila Cardoso, Antônio Felipe Silva Carvalho, Edvaldo S Lara, et al.
Cytokine|February 1, 2024
Alpha 1-acid glycoprotein is upregulated in severe COVID-19 patients and decreases neutrophil NETs in SARS-CoV-2 infectionFabiola Mestriner, Daniely F Francisco, Ligia C B Campos, et al.
Journal of Clinical Medicine|October 9, 2019
Cerebral Palsy: Early Markers of Clinical Phenotype and Functional OutcomeChrista Einspieler, Arend F Bos, Magdalena Krieber-Tomantschger, et al.
The Journal of Experimental Medicine|July 5, 2019
Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccinesNicholas Hernandez, Giorgia Bucciol, Leen Moens, et al.
Oecologia|December 2, 2025
Functional diversity of Brazilian bees: revealing the unique patterns of the NeotropicsGuaraci D Cordeiro, Tereza C Giannini, Patrick M Consorte, et al.
European Stroke Journal|February 27, 2026
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R studyMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
Journal of the American Heart Association|March 31, 2026
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted AnalysisMatteo Foschi, Lucio D'Anna, Francesca Gabriele, et al.
Pageof 109